Literature DB >> 15140120

Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism.

M Monreal1, A W A Lensing, M H Prins, M Bonet, J Fernández-Llamazares, J Muchart, P Prandoni, J Angel Jiménez.   

Abstract

Patients with acute venous thromboembolism have an increased risk for occult malignancy. Limited screening for these malignancies has become common practice but little is known about its usefulness. This is a prospective cohort follow-up study in consecutive patients with acute venous thromboembolism. All patients underwent a routine clinical evaluation for malignancy, if negative, followed by a limited diagnostic work-up consisting of abdominal and pelvic ultrasound and laboratory markers for malignancy. Clinical follow-up was conducted to detect screening failures. The routine clinical evaluation was performed in 864 patients and revealed malignancy in 34 (3.9%) of them. Among the remaining 830 patients the limited diagnostic work-up revealed 13 further malignancies. During follow-up, cancer became symptomatic in 14 patients who were negative for cancer at screening (sensitivity of limited diagnostic work-up, 48.1%). Malignancies that were identified by the limited diagnostic work-up were early stage in 61% of cases vs. 14% in cases occurring during follow-up. Most patients with occult cancer had idiopathic venous thromboembolism and were older than 70 years. A limited diagnostic work-up for occult cancer in patients with venous thromboembolism has the capacity to identify approximately one-half of the malignancies. Identified malignancies were predominantly in an early stage.

Entities:  

Mesh:

Year:  2004        PMID: 15140120     DOI: 10.1111/j.1538-7836.2004.00721.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  20 in total

1.  [Thromboembolism prophylaxis in old age].

Authors:  Gabriele Röhrig; Gerald Kolb
Journal:  Z Gerontol Geriatr       Date:  2018-04-05       Impact factor: 1.281

2.  Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.

Authors:  Miao Yu; Yun-Hong Wang; Ahmed M E Abdalla; Wen-Qi Liu; Fei Mei; Jian Wang; Chen-Xi Ouyang; Yi-Qing Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

3.  Extensive screening for occult cancer in unprovoked venous thromboembolism: not so useful?

Authors:  Christian Bracco; Cristina Serraino; Fulvio Pomero; Elisa Testa
Journal:  Intern Emerg Med       Date:  2016-04-08       Impact factor: 3.397

Review 4.  Venous thromboembolic disease and cancer.

Authors:  A Fennerty
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

5.  Venous thromboembolism and cancer risk among elderly adults in the United States.

Authors:  Morgan A Marks; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-08       Impact factor: 4.254

6.  A pilot study utilizing whole body 18 F-FDG-PET/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism.

Authors:  Matthew T Rondina; Nathan Wanner; Robert C Pendleton; Larry W Kraiss; Russell Vinik; Guy A Zimmerman; Marta Heilbrun; John M Hoffman; Kathryn A Morton
Journal:  Thromb Res       Date:  2011-07-29       Impact factor: 3.944

7.  The association of active cancer with venous thromboembolism location: a population-based study.

Authors:  Alfonso J Tafur; Henna Kalsi; Waldemar E Wysokinski; Robert D McBane; Aneel A Ashrani; Randolph S Marks; Daniel J Crusan; Tanya M Petterson; Kent R Bailey; John A Heit
Journal:  Mayo Clin Proc       Date:  2011-01       Impact factor: 7.616

8.  Frequency of malignancy is high in patients admitted for a first venous thromboembolism episode: an observational study.

Authors:  Diane Rouzaud; Jean-François Alexandra; Maria Chauchard; Myriam Delon; Antoine Dossier; Tiphaine Goulenok; Anne Perozziello; Thomas Papo; Karim Sacre
Journal:  J Thromb Thrombolysis       Date:  2016-10       Impact factor: 2.300

Review 9.  Colorectal cancer and hypercoagulability.

Authors:  Kazushige Kawai; Toshiaki Watanabe
Journal:  Surg Today       Date:  2013-05-14       Impact factor: 2.549

10.  Idiopathic venous thromboembolic disease is associated with a poorer prognosis from subsequent malignancy.

Authors:  A Jones; D L Stockton; A J Simpson; J T Murchison
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.